REDWOOD CITY, Calif.--(BUSINESS WIRE)--Karius®, Inc. today announced it has been awarded a contract from the Division of Research, Innovation, and Ventures (DRIVe), under the Biomedical Advanced ...
Mutation rates and biases in mutational sequence context can be influenced by endogenous cellular processes, environmental exposures, and genetic variation. All such mutagenic processes can leave ...
We conducted a systematic meta-analysis of 30 studies involving 3,287 patients with postoperative NSCLC to evaluate the diagnostic performance of ctDNA-based MRD testing for recurrence detection and ...
FOSTER CITY, Calif., May 30, 2025 /PRNewswire/ -- Adela, Inc., an innovator in blood testing for molecular residual disease (MRD) monitoring and early cancer detection through a proprietary ...
Chemo-praidict eBC: A deep learning solution for predicting pathological complete response on biopsies of breast cancer patients treated with neoadjuvant chemotherapy. Big data analysis of outcomes in ...
UCLA Health is joining a new effort to increase the ability to quickly respond to emerging pathogens by creating the capability to detect all existing and new respiratory RNA viruses in a single test.
HERNDON, Va.--(BUSINESS WIRE)--Fine Point Technologies today announced the release of Speed Master, a software module that enables highly efficient and scalable, vendor agnostic bulk speed testing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results